Whether you are building innovative gene therapies, targeting NASH, creating the next cure for a liver disease, or testing your small molecule for metabolism or toxicology, you need real data from from real human hepatocytes as early as possible.
That’s why for more than a decade, researchers have trusted the FRG platform for their liver studies. Yecuris FRG are chimeric animal models with more than 70% of the liver replaced with human hepatocytes providing researchers with actionable insights into liver-specific questions at the cellular, tissue, and animal level.
Company Details
- Employees
- 26
- Founded
- -
- Address
- Portland, Oregon 97224, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- yecuris.com
- Keywords
- Chimeric Animal Engineering, Drug Discovery and Development, Stem Cell Technologies, Human Health and Healing Advocates, Gene and Cell Therapy, NASH, Infectious Disease.
- HQ
- Portland, Oregon
Yecuris Corporation Questions
Yecuris Corporation's website is yecuris.com
Yecuris Corporation's LinkedIn profile is https://www.linkedin.com/company/yecuris-inc-
Yecuris Corporation has
26 employees.
View email and phone details for 26
employees at Yecuris Corporation.
Yecuris Corporation's industry is
Biotechnology Research
Yecuris Corporation's top competitors are
Jc Discovery,
Janvier Group Biosciences,
Janvier Labs,
Ubivac,
Mimabs Sas,
Edelris,
Physiogenex,
Xentech,
Cardiomedex,
Rd-Biotech.
Yecuris Corporation's categories are Biotechnology Research
Yecuris Corporation's founding year is 2007
